Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|March 11, 2024

Screening and Diagnosing of Ph+ ALL in Adults

The panel discusses optimal strategies for screening and detecting Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in patients across different treatment stages.

Episodes in this series

EP. 1 Overview of Characteristics Unique to Ph+ ALL

EP. 1 Overview of Characteristics Unique to Ph+ ALL

EP. 2 Timely Detection: Incidence and Prevalence of Ph+ ALL

EP. 2 Timely Detection: Incidence and Prevalence of Ph+ ALL

EP. 3 Supporting Ph+ ALL Patient: Emotional Challenges and Quality of Life

EP. 3 Supporting Ph+ ALL Patient: Emotional Challenges and Quality of Life

Video 4 - "Screening and Diagnosing of Ph+ ALL in Adults"

EP. 4 Screening and Diagnosing of Ph+ ALL in Adults

Video 5 - "Diagnosis and Treatment Timeline: Different Phases of Ph+ ALL Management"

EP. 5 Diagnosis and Treatment Timeline: Different Phases of Ph+ ALL Management

Video 6 - "Current Front-Line Targeted Treatments in Ph+ ALL"

EP. 6 Current Front-Line Targeted Treatments in Ph+ ALL

Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"

EP. 7 Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients

Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"

EP. 8 PhALLCON Trial: Efficacy and Safety of Ponatinib in Ph+ ALL Patients

Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"

EP. 9 Value-Based Care Models Optimizing Ph+ ALL Patient Care

VIdeo 10 - "Unmet Needs in Screening, Diagnosis, and Management of Ph+ ALL"

EP. 10 Unmet Needs in Screening, Diagnosis, and Management of Ph+ ALL

Video 11 - "Disparities in Access to Care for Ph+ ALL patients"

EP. 11 Disparities in Access to Care for Ph+ ALL patients

Video 12 - "The Future of Ph+ ALL Treatments"

EP. 12 The Future of Ph+ ALL Treatments

Video 13 - "Concluding Thoughts on Ph+ ALL Treatment"

EP. 13 Concluding Thoughts on Ph+ ALL Treatment

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Committee meeting | Image credit: Open Horizon - stock.adobe.com

FDA Advisory Panel Votes Against Approval of Deramiocel for DMD

ByPearl Steinzor

July 30th 2026

MRI of the brain | Image Credit: DedMityay - stock.adobe.com

MASLD, MASH Linked to Higher Mild Cognitive Impairment Risk, Lower Dementia Odds

ByBrooke McCormick

July 30th 2026

Chronic hand eczema. | Image Credit: IIIRusya - stock.adobe.com

Delgocitinib Cream Succeeds in First Phase 3 Trial for Teens With Hand Eczema

BySkylar Jeremias

July 30th 2026

Nitipong Permpalung, MD

Early Remdesivir May Reduce Graft Loss in Kidney Transplant Recipients With COVID-19: Nitipong Permpalung, MD, MPH

BySabrina McCrear,Nitipong Permpalung, MD, MPH

July 30th 2026

ALL Graphic | Image Credit: Sviatlana - stock.adobe.com

B-ALL Data Reinforce Push for Risk-Tailored Care

ByMaggie L. Shaw

July 30th 2026

Trending on AJMC

Judge Denies Preliminary Injunction in Medicaid Work Requirements Case

AHRQ Grant Freeze Halts Patient Safety Research Nationwide

Contributor: Artificial Intelligence Grows Across Health Care, Led by Administrative Processes

FDA Advisory Panel Votes Against Approval of Deramiocel for DMD

The Future of RRFL: Personalized Treatment, Novel Agents, and Moving Beyond Chemotherapy